Charbonnel B - Search Results

1

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis.

Schernthaner G, Barnett AH, Betteridge DJ, Carmena R, Ceriello A, Charbonnel B, Hanefeld M, Lehmann R, Malecki MT, Nesto R, Pirags V, Scheen A, Seufert J, Sjohölm A, Tsatsoulis A, DeFronzo R. Schernthaner G, et al. Among authors: charbonnel b. Diabetologia. 2010 Jul;53(7):1258-69. doi: 10.1007/s00125-010-1702-3. Epub 2010 Mar 31. Diabetologia. 2010. PMID: 20352408 Free PMC article.

2

Effects of glucose-lowering agents on vascular outcomes in type 2 diabetes: a critical reappraisal.

Scheen AJ, Charbonnel B. Scheen AJ, et al. Among authors: charbonnel b. Diabetes Metab. 2014 Jun;40(3):176-85. doi: 10.1016/j.diabet.2014.03.004. Epub 2014 Apr 30. Diabetes Metab. 2014. PMID: 24792220 Free article. Review.

3

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes.

Charbonnel B, Schernthaner G, Brunetti P, Matthews DR, Urquhart R, Tan MH, Hanefeld M. Charbonnel B, et al. Diabetologia. 2005 Jun;48(6):1093-104. doi: 10.1007/s00125-005-1751-1. Epub 2005 May 12. Diabetologia. 2005. PMID: 15889234 Free article. Clinical Trial.

4

Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial.

Schernthaner G, Matthews DR, Charbonnel B, Hanefeld M, Brunetti P; Quartet [corrected] Study Group. Schernthaner G, et al. Among authors: charbonnel b. J Clin Endocrinol Metab. 2004 Dec;89(12):6068-76. doi: 10.1210/jc.2003-030861. J Clin Endocrinol Metab. 2004. PMID: 15579760 Clinical Trial.

5

Long-term glycaemic control with metformin-sulphonylurea-pioglitazone triple therapy in PROactive (PROactive 17).

Scheen AJ, Tan MH, Betteridge DJ, Birkeland K, Schmitz O, Charbonnel B; PROactive investigators. Scheen AJ, et al. Among authors: charbonnel b. Diabet Med. 2009 Oct;26(10):1033-9. doi: 10.1111/j.1464-5491.2009.02816.x. Diabet Med. 2009. PMID: 19900236 Free article. Clinical Trial.

6

Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study.

Matthews DR, Charbonnel BH, Hanefeld M, Brunetti P, Schernthaner G. Matthews DR, et al. Among authors: charbonnel bh. Diabetes Metab Res Rev. 2005 Mar-Apr;21(2):167-74. doi: 10.1002/dmrr.478. Diabetes Metab Res Rev. 2005. PMID: 15386821 Clinical Trial.

7

Long-term glycaemic effects of pioglitazone compared with placebo as add-on treatment to metformin or sulphonylurea monotherapy in PROactive (PROactive 18).

Scheen AJ, Tan MH, Betteridge DJ, Birkeland K, Schmitz O, Charbonnel B; PROactive investigators. Scheen AJ, et al. Among authors: charbonnel b. Diabet Med. 2009 Dec;26(12):1242-9. doi: 10.1111/j.1464-5491.2009.02857.x. Diabet Med. 2009. PMID: 20002476 Free article. Clinical Trial.

8

Dipeptidyl peptidase-4 inhibitors in triple oral therapy regimens in patients with type 2 diabetes mellitus.

Barnett AH, Charbonnel B, Moses RG, Kalra S. Barnett AH, et al. Among authors: charbonnel b. Curr Med Res Opin. 2015;31(10):1919-31. doi: 10.1185/03007995.2015.1081589. Epub 2015 Sep 11. Curr Med Res Opin. 2015. PMID: 26361231 Review.

9

Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials.

Porta M, Hainer JW, Jansson SO, Malm A, Bilous R, Chaturvedi N, Fuller JH, Klein R, Orchard T, Parving HH, Sjølie AK; DIRECT Study Group. Porta M, et al. Diabetologia. 2011 Jun;54(6):1298-303. doi: 10.1007/s00125-010-2040-1. Epub 2011 Jan 12. Diabetologia. 2011. PMID: 21225239 Free article. Clinical Trial.

10

A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.

Charbonnel BH, Matthews DR, Schernthaner G, Hanefeld M, Brunetti P; QUARTET Study Group. Charbonnel BH, et al. Diabet Med. 2005 Apr;22(4):399-405. doi: 10.1111/j.1464-5491.2004.01426.x. Diabet Med. 2005. PMID: 15787663 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

298 results

Search Page